A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV
The cost effectiveness of using novel HCV treatment option, telaprevir and boceprevir, should depend on patients’ respond to conventional PEG-INFα and ribavirin therapy. The study of pharmacogenomics, interleukin-28B (IL-28B) polymorphisms, accompanied with the information of HCV genotypes are sugge...
Main Authors: | Yuen, King-tai, 袁敬弟 |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/193555 |
Similar Items
-
FREQUENCY OF VARIOUS HEPATITIS C VIRUS (HCV) GENOTYPES IN FAISALABAD AND SURROUNDING DISTRICTS
by: Khalid Mehmood Yahya, et al.
Published: (2013-12-01) -
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases
by: Jianming Wei, et al.
Published: (2021-07-01) -
Liver histology in co-infection of hepatitis C virus (HCV) and Hepatitis G virus (HGV)
by: STRAUSS Edna, et al.
Published: (2002-01-01) -
Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01) -
Hepatitis C III. Estudio laparoscópico, histológico y niveles séricos de alanina aminotransferasa en 160 pacientes seropositivos al virus de la hepatitis C Hepatitis C III. Laparoscopic and histological study and serum levels of alanine aminotransferase in 160 HCV seropositive patients
by: Jorge Valdés Moreno, et al.
Published: (2005-03-01)